Trials are already being prioritised, just not at the institutional level

Research output: Contribution to journalLetterpeer-review

12 Downloads (Pure)

Abstract

Successful clinical trials are important for all of us, but they can be extremely complicated to design and run, so work must be done to consider what commonly goes wrong and how these issues can be addressed. Gelinas et al suggest an ethical argument for institutional prioritisation of clinical trials conducted among limited populations. This is to ensure successful recruitment and prevent competing trials rendering each other irrelevant through lack of statistical power. But they overlook the fact that effective prioritisation already occurs, and their suggestion produces yet another hurdle for researchers to overcome.
Original languageEnglish
Pages (from-to)814-815
Number of pages2
JournalJournal of Medical Ethics
Volume42
Issue number12
Early online date6 Feb 2017
DOIs
Publication statusPublished - 23 Nov 2017

Keywords

  • Trials
  • drugs
  • ethics
  • Research
  • methodology

Fingerprint

Dive into the research topics of 'Trials are already being prioritised, just not at the institutional level'. Together they form a unique fingerprint.

Cite this